Lori Anderson v. K-V Pharmaceutical Company
Court of Appeals for the Eighth Circuit
1Opinion of the Court
SHEPHERD, Circuit Judge.
This securities fraud class action involves a class of plaintiffs who purchased or otherwise acquired shares of K-V Pharmaceutical Company stock during the period in which the company launched and marketed Makena, its new prescription drug. The plaintiffs allege that K-V and three of its officers (collectively K-V) made materially false or misleading statements or omissions related to the product launch. The district court 2 granted K-Vs motion to dismiss, holding the challenged statements were protected by the safe-harbor provision of the Private Securities Litigation…
2Cases cited9 opinions
- Popoalii v. Correctional Medical ServicesCourt of Appeals for the Eighth Circuit · 2008
- Robert R. Wisdom Nancy J. Wisdom v. First Midwest Bank, of Poplar Bluff Jerry F. McLane Jerry Dorton Joey McLaneCourt of Appeals for the First Circuit · 1999
- Auto Services Co., Inc. v. KPMG, LLPCourt of Appeals for the Eighth Circuit · 2008
- In Re Aetna, Inc. Securities LitigationCourt of Appeals for the Third Circuit · 2010
- Horizon Asset Management Inc. v. H & R BLOCK, INC.Court of Appeals for the Eighth Circuit · 2009
4 more not listed; retrieve them via the Exa API.
3Cited by83 opinions
- SPV-LS, LLC v. The Estate of Nancy BergmanCourt of Appeals for the Eighth Circuit · 2019
- Kevin Dougherty v. Esperion TherapeuticsCourt of Appeals for the Sixth Circuit · 2018
- United States v. Donald Clark LugerCourt of Appeals for the Eighth Circuit · 2016
- Rand-Heart of New York, Inc. v. James P. DolanCourt of Appeals for the Eighth Circuit · 2016
- Police Officers Pension Fund v. Meredith CorporationCourt of Appeals for the Eighth Circuit · 2021
78 more not listed; retrieve them via the Exa API.